Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blau

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Neuroendocrinology|March 26, 2026
Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1Serguei V Kozlov, Sunita K Agarwal, Theresa M Guerin, et al.
JCI Insight|April 20, 2018
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover studyJenny E Blau, Viviana Bauman, Ellen M Conway, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2020
Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited PredispositionAmit Tirosh, Jonathan Keith Killian, David Petersen, et al.
Contemporary Clinical Trials Communications|February 7, 2025
Design and rationale for a global novel non-invasive screening observational study using genetics and non-invasive methodologies to identify at-risk MASLD participants: The ALIGN studySamuel J Daniels, Karin Nelander, John Eriksson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2025
Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLDValentina Flagiello, Paolo Gallo, Francesca Terracciani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort studyYuya Seko, Kanji Yamaguchi, Toshihide Shima, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 5, 2020
18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytomaAisha A Tepede, James Welch, Maya Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2020
Patients With MEN1 Are at an Increased Risk for Venous ThromboembolismMaya E Lee, Yashira M Ortega-Sustache, Sunita K Agarwal, et al.
JCI Insight|February 13, 2025
Genotype-phenotype correlation in multiple endocrine neoplasia type 1Charlita C Worthy, Rana Tora, Chandra N Uttarkar, et al.
Endocrine-Related Cancer|September 13, 2021
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locusAdel Mandl, James M Welch, Gayathri Kapoor, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Neuroendocrinology|March 26, 2026
Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1Serguei V Kozlov, Sunita K Agarwal, Theresa M Guerin, et al.
JCI Insight|April 20, 2018
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover studyJenny E Blau, Viviana Bauman, Ellen M Conway, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2020
Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited PredispositionAmit Tirosh, Jonathan Keith Killian, David Petersen, et al.
Contemporary Clinical Trials Communications|February 7, 2025
Design and rationale for a global novel non-invasive screening observational study using genetics and non-invasive methodologies to identify at-risk MASLD participants: The ALIGN studySamuel J Daniels, Karin Nelander, John Eriksson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2025
Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLDValentina Flagiello, Paolo Gallo, Francesca Terracciani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort studyYuya Seko, Kanji Yamaguchi, Toshihide Shima, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 5, 2020
18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytomaAisha A Tepede, James Welch, Maya Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2020
Patients With MEN1 Are at an Increased Risk for Venous ThromboembolismMaya E Lee, Yashira M Ortega-Sustache, Sunita K Agarwal, et al.
JCI Insight|February 13, 2025
Genotype-phenotype correlation in multiple endocrine neoplasia type 1Charlita C Worthy, Rana Tora, Chandra N Uttarkar, et al.
Endocrine-Related Cancer|September 13, 2021
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locusAdel Mandl, James M Welch, Gayathri Kapoor, et al.
Pageof 7